FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003085100> ?p ?o ?g. }

• W2003085100 endingPage "242" @default.
• W2003085100 startingPage "235" @default.
• W2003085100 abstract "Systemic and topical administration routes of tacrolimus and cyclosporin A (CsA) were compared in effects on early and late phases of elicited T-cell-mediated contact sensitivity (CS), and effects on early and late phases of cutaneous immunoglobulin E (IgE) antibody-mediated hypersensitivity responses in mice. Thus, both CS and IgE responses in the skin have an early mast-cell-dependent phase, and also a late inflammatory phase. We measured the effects of both immunosuppressants on both phases of the respective T cell versus IgE responses. Systemic administration of both agents completely suppressed CS and IgE late-phase responses, but failed to affect either early phase. In contrast, when topical CsA was used, low doses abolished the early phase of IgE responses, but even high doses did not inhibit the early phase of CS. Conversely, topical tacrolimus inhibited the early phase of CS more potently than the early phase of cutaneous IgE hypersensitivity responses. Thus, topical treatment was needed to inhibit the early phases and the two agents acted differentially, suggesting differing susceptibility of the early phases, that are probably due to different signalling mechanisms. These studies underscore the potential value of topical administration of these powerful immunosuppressive agents in the treatment of allergic diseases that exhibit features of early-phase mast-cell-dependent inflammation, and late inflammation due to mast cells or to T cells, such as atopic dermatitis or asthma, since the early phase is predominantly susceptible to topical application, while the last phase of both IgE and T-cell inflammation responds to systemic treatment with both agents." @default.
• W2003085100 created "2016-06-24" @default.
• W2003085100 creator A5005513749 @default.
• W2003085100 creator A5052511743 @default.
• W2003085100 creator A5059837134 @default.
• W2003085100 date "2001-10-01" @default.
• W2003085100 modified "2023-10-16" @default.
• W2003085100 title "Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity" @default.
• W2003085100 cites W1484647582 @default.
• W2003085100 cites W1530102923 @default.
• W2003085100 cites W1542788212 @default.
• W2003085100 cites W1543230017 @default.
• W2003085100 cites W1543640403 @default.
• W2003085100 cites W1558591240 @default.
• W2003085100 cites W1563458114 @default.
• W2003085100 cites W1575661019 @default.
• W2003085100 cites W1590126152 @default.
• W2003085100 cites W1592990364 @default.
• W2003085100 cites W1629760906 @default.
• W2003085100 cites W1664757944 @default.
• W2003085100 cites W1882029866 @default.
• W2003085100 cites W1908908549 @default.
• W2003085100 cites W1914932411 @default.
• W2003085100 cites W1968775322 @default.
• W2003085100 cites W1969971113 @default.
• W2003085100 cites W1970192183 @default.
• W2003085100 cites W1975891149 @default.
• W2003085100 cites W1981264390 @default.
• W2003085100 cites W1984754431 @default.
• W2003085100 cites W1984947099 @default.
• W2003085100 cites W1996394259 @default.
• W2003085100 cites W1996853954 @default.
• W2003085100 cites W2004716997 @default.
• W2003085100 cites W2005873886 @default.
• W2003085100 cites W2014587198 @default.
• W2003085100 cites W2019942547 @default.
• W2003085100 cites W2030886807 @default.
• W2003085100 cites W2033838356 @default.
• W2003085100 cites W2034269975 @default.
• W2003085100 cites W2041512157 @default.
• W2003085100 cites W2043378323 @default.
• W2003085100 cites W2048775679 @default.
• W2003085100 cites W2054199244 @default.
• W2003085100 cites W2060659567 @default.
• W2003085100 cites W2102291237 @default.
• W2003085100 cites W2108794906 @default.
• W2003085100 cites W2113581200 @default.
• W2003085100 cites W2114858319 @default.
• W2003085100 cites W2121435153 @default.
• W2003085100 cites W2122022191 @default.
• W2003085100 cites W2403548925 @default.
• W2003085100 cites W4232033059 @default.
• W2003085100 cites W4240604686 @default.
• W2003085100 cites W4241692185 @default.
• W2003085100 cites W4313347712 @default.
• W2003085100 doi "https://doi.org/10.1046/j.1365-2567.2001.01288.x" @default.
• W2003085100 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1783292" @default.
• W2003085100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11683964" @default.
• W2003085100 hasPublicationYear "2001" @default.
• W2003085100 type Work @default.
• W2003085100 sameAs 2003085100 @default.
• W2003085100 citedByCount "19" @default.
• W2003085100 countsByYear W20030851002012 @default.
• W2003085100 countsByYear W20030851002017 @default.
• W2003085100 countsByYear W20030851002018 @default.
• W2003085100 countsByYear W20030851002019 @default.
• W2003085100 countsByYear W20030851002021 @default.
• W2003085100 countsByYear W20030851002023 @default.
• W2003085100 crossrefType "journal-article" @default.
• W2003085100 hasAuthorship W2003085100A5005513749 @default.
• W2003085100 hasAuthorship W2003085100A5052511743 @default.
• W2003085100 hasAuthorship W2003085100A5059837134 @default.
• W2003085100 hasConcept C126322002 @default.
• W2003085100 hasConcept C141105273 @default.
• W2003085100 hasConcept C159654299 @default.
• W2003085100 hasConcept C203014093 @default.
• W2003085100 hasConcept C2776914184 @default.
• W2003085100 hasConcept C2778329239 @default.
• W2003085100 hasConcept C2779726688 @default.
• W2003085100 hasConcept C2909675724 @default.
• W2003085100 hasConcept C2911091166 @default.
• W2003085100 hasConcept C71924100 @default.
• W2003085100 hasConcept C98274493 @default.
• W2003085100 hasConceptScore W2003085100C126322002 @default.
• W2003085100 hasConceptScore W2003085100C141105273 @default.
• W2003085100 hasConceptScore W2003085100C159654299 @default.
• W2003085100 hasConceptScore W2003085100C203014093 @default.
• W2003085100 hasConceptScore W2003085100C2776914184 @default.
• W2003085100 hasConceptScore W2003085100C2778329239 @default.
• W2003085100 hasConceptScore W2003085100C2779726688 @default.
• W2003085100 hasConceptScore W2003085100C2909675724 @default.
• W2003085100 hasConceptScore W2003085100C2911091166 @default.
• W2003085100 hasConceptScore W2003085100C71924100 @default.
• W2003085100 hasConceptScore W2003085100C98274493 @default.
• W2003085100 hasIssue "2" @default.
• W2003085100 hasLocation W20030851001 @default.
• W2003085100 hasLocation W20030851002 @default.
• W2003085100 hasOpenAccess W2003085100 @default.

• next